PATENT CLAIM ANALYSIS

Application Number: 15769054
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "338000"]

Abstract:
The present invention provides a method for treating a cancer in a subject in need thereof, comprising administering a specific MDM2 inhibitor to the subject according to a specific dosage regimen and a pharmaceutical composition for use in treating a cancer according to the dosage regimen. The present invention also provides a method for treating liposarcoma in a subject in need thereof, comprising administering a specific MDM2 inhibitor to the subject and a pharmaceutical composition for use in treating liposarcoma, comprising the MDM2 inhibitor.

Claim (Index 28):
A pharmaceutical composition according to  claim 9 , wherein each cycle has a dosing period of about 21 days, in which the compound or salt thereof is administered daily at a daily dosage of about 180 mg to about 250 mg, followed by a rest period of about 7 days, in which any of the compound and salt thereof is not administered.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 2.87097
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14401357', '15719636', '12265553', '15914479', '10650025']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7790858316982046
- 35 USC 102 Novelty (BERT): 0.51112585931353
- Combined Prediction Score: 0.7522898344597372
- Mean Citation Score: 257.785686
- Max Citation Score: 264.94675
- Similarity Product: 174.66959316471218

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test